The inhibition of neutrophil adhesion to endothelial cells obtained with plasma samples from survivor COVID-19 patients was significantly inhibited by anti-CD160 treatment, suggesting a role of HLA-G/CD160 interaction in regulating neutrophil adhesion to endothelial cells. The gene discussed is CD160; the disease is COVID-19.